JF
Jump Financial Portfolio holdings
AUM
$8.14B
1-Year Return
18.67%
This Quarter Return
-3.61%
1 Year Return
+18.67%
3 Year Return
+54.31%
5 Year Return
+107.56%
10 Year Return
–
AUM
$2.57B
AUM Growth
+$237M
(+10%)
Cap. Flow
+$301M
Cap. Flow
% of AUM
11.7%
Top 10 Holdings %
Top 10 Hldgs %
8.13%
Holding
2,154
New
603
Increased
475
Reduced
443
Closed
629
Top Buys
| 1 |
SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$18.5M |
| 2 |
Apple
AAPL
|
+$18M |
| 3 |
Microsoft
MSFT
|
+$16.3M |
| 4 |
ProShares UltraPro QQQ
TQQQ
|
+$15.6M |
| 5 |
ProShares Ultra QQQ
QLD
|
+$12.3M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$94.5M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$77.8M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$39.9M |
| 4 |
Direxion Daily S&P 500 Bull 3x Shares
SPXL
|
+$10.4M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$9.31M |
Sector Composition
| 1 | Technology | 19.73% |
| 2 | Healthcare | 12% |
| 3 | Financials | 11.95% |
| 4 | Industrials | 10% |
| 5 | Consumer Discretionary | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Vanda Pharmaceuticals
VNDA
$265M
| $504K | 0.02% |
51,000
-3,100
| -6% | -$30.6K |
|
|
EBIX
902
DELISTED
Ebix Inc
EBIX
| $503K | 0.02% |
+26,500
| New | +$503K |
|
903
Itaú Unibanco
ITUB
$75.7B
| $501K | 0.02% |
106,583
-594,538
| -85% | -$2.79M |
|
904
Sprinklr
CXM
$1.88B
| $500K | 0.02% |
+54,237
| New | +$500K |
|
905
Health Catalyst
HCAT
$229M
| $497K | 0.02% |
+51,250
| New | +$497K |
|
906
OneSpan
OSPN
$578M
| $497K | 0.02% |
57,692
+29,092
| +102% | +$251K |
|
907
Booking.com
BKNG
$177B
| $494K | 0.02% |
+301
| New | +$494K |
|
908
Distribution Solutions Group
DSGR
$1.43B
| $493K | 0.02% |
+35,056
| New | +$493K |
|
|
GTHX
909
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $493K | 0.02% |
39,500
-1,554
| -4% | -$19.4K |
|
910
Autodesk
ADSK
$69B
| $491K | 0.02% |
+2,629
| New | +$491K |
|
911
ON Semiconductor
ON
$19.7B
| $490K | 0.02% |
+7,858
| New | +$490K |
|
912
Ultragenyx Pharmaceutical
RARE
$3.02B
| $489K | 0.02% |
+11,798
| New | +$489K |
|
913
Labcorp
LH
$22.7B
| $488K | 0.02% |
2,771
-20,194
| -88% | -$3.56M |
|
914
Essex Property Trust
ESS
$17B
| $484K | 0.02% |
2,000
-19,348
| -91% | -$4.68M |
|
915
Universal Display
OLED
$6.52B
| $482K | 0.02% |
+5,104
| New | +$482K |
|
916
C.H. Robinson
CHRW
$15.1B
| $481K | 0.02% |
+4,999
| New | +$481K |
|
917
Broadstone Net Lease
BNL
$3.52B
| $480K | 0.02% |
+30,900
| New | +$480K |
|
918
Lincoln Electric
LECO
$13.4B
| $478K | 0.02% |
3,802
-3,398
| -47% | -$427K |
|
919
Franklin Resources
BEN
$12.6B
| $476K | 0.02% |
+22,130
| New | +$476K |
|
920
Cadre Holdings
CDRE
$1.28B
| $469K | 0.02% |
19,500
-11,367
| -37% | -$273K |
|
921
Intellia Therapeutics
NTLA
$1.21B
| $467K | 0.02% |
8,352
-64,048
| -88% | -$3.58M |
|
|
ITCI
922
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $465K | 0.02% |
+10,000
| New | +$465K |
|
923
Organogenesis Holdings
ORGO
$617M
| $464K | 0.02% |
143,414
+107,410
| +298% | +$348K |
|
924
ProAssurance
PRA
$1.22B
| $464K | 0.02% |
+23,762
| New | +$464K |
|
925
argenx
ARGX
$46.7B
| $462K | 0.02% |
1,309
-12,191
| -90% | -$4.3M |
|